4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-23-047880
Director bought 82,052 shares at an average $1.32 ($107,898)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lamond David Director | 2023-08-30 | Purchase | +41,026 | $1.31 | $53,744 | 2,138,135 | I: show line 1 in the form |
| Lamond David Director | 2023-08-31 | Purchase | +41,026 | $1.32 | $54,154 | 2,179,161 | I: show line 2 in the form |
| Open-market purchases · 82,052 sh · avg $1.32 · $107,898 | |||||||
Loading xslF345X05/doc4.xml…